Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines
Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.96.5.2268
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 2, 1999
Authors
Publisher
Proceedings of the National Academy of Sciences